Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes.
Cooper-DeHoff
Rhonda
R
Pepine
Carl J
CJ
D000083:Acetanilides; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000503:physiopathology; D017079:Exercise Tolerance; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D000069458:Ranolazine
D000083:Acetanilides; D002316:Cardiotonic Agents; D010879:Piperazines; D000069458:Ranolazine